Medscape1h
Reducing Risk, One Mask at a Time: What the Science Says
Conversely, the decision to relax and eliminate mask regulations has had consequences that have received little attention. As ...
Long COVID Breakthrough: Spike Proteins Persist in Brain for Years
Researchers have discovered that the SARS-CoV-2 spike protein persists in the brain and skull bone marrow for years after ...
Nature1d
What will viruses do next? AI is helping scientists predict their evolution
The holy grail of pandemic preparedness is being able to predict how a virus will evolve just by looking at its genetic ...
COVID-19 Turns 5: Looking Back And Looking Forward
The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...
earth1d
Study reveals surprising mutations in SARS-CoV-2 virus
A study in Ecuador reveals the rapid emergence of SARS-CoV-2 variants, highlighting the importance of strengthening genomic ...
Hosted on MSN1d
Nuclein’s DASH SARS-CoV-2 & Flu A/B Test gains FDA clearance and CLIA waiver
Nuclein’s DASH SARS-CoV-2 & Flu A/B Test, which is designed for use with the DASH Rapid PCR System, has gained the US Food ...
Republican senators slam spy chiefs operating ‘in the shadows’ for ‘politicized’ COVID origins probe
For years, we’ve exposed the federal government’s role — especially the Intelligence Community — in concealing the origins of ...
What COVID tried to teach us — and why it will matter in the next pandemic
The intervening years have both sped and crawled by, too busy at times to take stock of all that has changed, too plodding to ...
Paxlovid may help some long COVID patients: Research
A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...
COVID-19 Wastewater Viral Levels 'Very High' at Christmas, Map Reveals
Some 16 states had "very high" levels of the virus present in wastewater during the week of Christmas, an increase from the week before.
Nuclein Receives Dual FDA 510(k) Clearance and CLIA Waiver for DASH® SARS-CoV-2 & Flu A/B Test for use on the DASH® Rapid PCR System
Nuclein, a leader in rapid, point-of-care molecular diagnostics, today announced it has received U.S. Food and Drug ...
Trinity Investors Celebrates Nuclein’s Dual FDA Clearance and CLIA Waiver for DASH® SARS-CoV-2 & Flu A/B Test
SOUTHLAKE, Texas, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Trinity Investors, a leading alternative asset management firm, proudly announces a significant milestone achieved by portfolio company Nuclein, LLC ...